EMA has issued a ban on certain cough medications

The European Medicines Agency (EMA) has suspended cough medicine containing fenspiride with immediate effect. This is due to repeated reports from studies showing that ingestion of the active substance could impair cardiac function.

The suspension decision on fenspiride is a precautionary measure

The European Medicines Agency (EMA) has suspended cough medicine containing fenspiride with immediate effect. This is due to repeated reports from studies showing that ingestion of the active substance could impair cardiac function.

The temporary ban on fenspiride-containing cough medicines was based on the results of some non-clinical studies which had concluded that fenspiride could potentially contribute to long QT in humans. This seems to confirm the previously postulated suspicion of a connection between fenspiride and a long QT occurrence. This has been previously described in a limited number of case reports.

At the present time, however, the block is a mere precautionary measure. EMA will first examine the entire available evidence and then derive new recommendations. Whether the marketing authorizations for fenspiride drugs in the EU will have to be changed as a result remains to be seen.

In the meantime, EMA advises all physicians to recommend that patients stop taking fenspiride-containing drugs for the duration of this examination. Until then, reference should be made to alternative formulations. Upon completion of the investigation, EMA will issue an updated recommendation for medical professionals.

The following medications are affected by the ban: Elofen, Epistat, Eurefin, Eurespal, Fenspogal, Fosidal, Kudorp, Pneumorel, Pulneo, Еуреспал and Сиресп.

Source:
European Medicines Agency. Fenspiride containing medicinal products. 15 February 2019

esanum is an online network for approved doctors

esanum is the medical platform on the Internet. Here, doctors have the opportunity to get in touch with a multitude of colleagues and to share interdisciplinary experiences. Discussions include both cases and observations from practice, as well as news and developments from everyday medical practice.

esanum ist ein Online-Netzwerk für approbierte Ärzte

esanum ist die Ärzteplattform im Internet. Hier haben Ärzte die Möglichkeit, mit einer Vielzahl von Kollegen in Kontakt zu treten und interdisziplinär Erfahrungen auszutauschen. Diskussionen umfassen sowohl Fälle und Beobachtungen aus der Praxis, als auch Neuigkeiten und Entwicklungen aus dem medizinischen Alltag.

Esanum est un réseau en ligne pour les médecins agréés

esanum est un réseau social pour les médecins. Rejoignez la communauté et partagez votre expérience avec vos confrères. Actualités santé, comptes-rendus d'études scientifiques et congrès médicaux : retrouvez toute l'actualité de votre spécialité médicale sur esanum.